Advertisement

Ureter dose optimization during image guided brachytherapy for cervical cancer

      Abstract

      PURPOSE

      In the era of image guided radiotherapy and interstitial needle use, radiation dose to ureters can cause toxicity.

      METHODS

      A retrospective analysis of 106 patients with cervical cancer was performed to investigate ureter dose in brachytherapy patients. Re-optimization of brachytherapy treatment plans in 20 MRI planned patients was performed to reduce ureter dose whilst maintaining HRCTV D90 and OAR dose constraints.

      RESULTS

      A total of 212 ureters were contoured and dose recorded. The crude incidence of ureteric stenosis was 6.6%. Ureter dose for all patients was 75.8 Gy and 74.4 Gy on the right and left respectively. A cohort of 20 MRI planned patients were reoptimized to reduce dose to ureters. Ureter dose was reduced from 91.1 Gy to 84.4 Gy and 73.9 Gy to 67.8 Gy on the right and left side respectively. A subgroup of patients with HRCTV D90 ≥84.3 Gy prior to reoptimisation saw a greater reduction in ureter dose of 13.3%. These were smaller tumours with better HRCTV coverage at the outset. Larger tumours with poorer HRCTV coverage (<84.3 Gy) saw a smaller reduction in ureter dose of 6.4%. Organ at risk dose to rectum, sigmoid and bladder were also significantly reduced.

      CONCLUSIONS

      Patients treated with MRI guided brachytherapy and interstitial needles are at risk of ureteric stenosis. Contouring ureters and setting dose constraints should be considered to reduce ureteric dose while tracking HRCTV coverage

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brachytherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fokdal L.
        • et al.
        Risk factors for ureteral stricture after radiochemotherapy including image guided adaptive brachytherapy in cervical cancer: results from the EMBRACE studies.
        Int J Radiat Oncol Biol Phys. 2019; 103: 887-894
        • Buglione M.
        • et al.
        [Post-radiation pelvic disease and ureteral stenosis: physiopathology and evolution in the patient treated for cervical carcinoma. Review of the literature and experience of the Radium Institute].
        Arch Ital Urol Androl. 2002; 74: 6-11
        • Parliament M.
        • et al.
        Obstructive ureteropathy following radiation therapy for carcinoma of the cervix.
        Gynecol Oncol. 1989; 33: 237-240
        • Siegel J.
        • et al.
        Ureteral strictures and reconstruction in the cancer survivor.
        Curr Opin Urol. 2014; 24: 421-426
        • McIntyre J.F.
        • et al.
        Ureteral stricture as a late complication of radiotherapy for stage IB carcinoma of the uterine cervix.
        Cancer. 1995; 75: 836-843
        • Gemer O.
        • et al.
        A radiological study on the anatomical proximity of the ureters and the cervix.
        Int Urogynecol J Pelvic Floor Dysfunct. 2007; 18: 991-995
        • Rodríguez-López J.L.
        • et al.
        Ureteral stenosis after 3D MRI-based brachytherapy for cervical cancer - Have we identified all the risk factors?.
        Radiother Oncol. 2021; 155: 86-92https://doi.org/10.1016/j.radonc.2020.10.010
        • Peters M.
        • et al.
        Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: late toxicity and dose constraints.
        Radiother Oncol. 2015; 117: 262-269
        • Hsu I.C.
        • et al.
        Dosimetric analysis of radiation therapy oncology group 0321: the importance of urethral dose.
        Pract Radiat Oncol. 2014; 4: 27-34
        • Tanderup K.
        • et al.
        Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
        Radiother Oncol. 2016; 120: 441-446
        • Pecorelli s
        • et al.
        Revised FIGO staging for carcinoma of the cervix.
        Int J Gynaecol Obstet. 2009; 105: 107-108
        • Jox J.D.
        • et al.
        Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC).
        Int J Radiat Oncol Biol Phys. 1995; 31: 1341-1346
      1. Cancer Research UK. Cancer statistics-cervix. Available at: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/cervical-cancer#heading-Zero 2019.

        • Potter R.
        • et al.
        Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer.
        Radiother Oncol. 2011; 100: 116-123
        • Sturdza A.
        • et al.
        Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study.
        Radiother Oncol. 2016; 120: 428-433
        • Charra-Brunaud C.
        • et al.
        Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.
        Radiother Oncol. 2012; 103: 305-313
        • Mundt A.J.
        • et al.
        Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies1 1Its contents are solely the responsibility of the authors and do not necessarily reflect the official views of the Illinois Department of Public Health.
        Int J Radiat Oncol Biol Phys. 2002; 52: 1330-1337
        • Mundt A.J.
        • Mell L.K.
        • Roeske J.C.
        Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy.
        Int J Radiat Oncol Biol Phys. 2003; 56: 1354-1360
        • Hasselle M.D.
        • et al.
        Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix.
        Int J Radiat Oncol Biol Phys. 2011; 80: 1436-1445
        • Goldfarb R.A.
        • et al.
        The burden of chronic ureteral stenting in cervical cancer survivors.
        Int Braz J Urol. 2017; 43: 104-111
        • Fokdal L.
        • et al.
        Risk factors for ureteral stricture after radiochemotherapy including image guided adaptive brachytherapy in cervical cancer: results From the EMBRACE studies.
        Int J Radiat Oncol Biol Phys. 2019; 103: 887-894
        • Fujikawa K.
        • et al.
        High incidence of severe urologic complications following radiotherapy for cervical cancer in Japanese women.
        Gynecol Oncol. 2001; 80: 21-23
        • Wit E.M.K.
        • et al.
        Urological complications after treatment of cervical cancer.
        Nat Rev Uro. 2014; 11: 110-117https://doi.org/10.1038/nrurol.2013.323
        • Glaser M
        Complications of intracavitary brachytherapy for gynecologic cancers and their management: a comprehensive review.
        Brachytherapy. 2022; 20 (Doi:)https://doi.org/10.1016/j.brachy.2020.11.011
        • Dauplat J.
        • et al.
        [Ureteral dosimetry during gynecological curietherapy. Possible effects on the occurrence of postoperative ureteral complications].
        J Urol (Paris). 1987; 93: 1s-17
        • Kinsell T.J.
        • et al.
        Tolerance of the canine bladder to intraoperative radiation therapy: an experimental study.
        Int J Radiat Oncol Biol Phys. 1988; 14: 939-946https://doi.org/10.1016/0360-3016(88)90016-8
        • Shaw E.G.
        • et al.
        Peripheral nerve and ureteral tolerance to intraoperative radiation therapy: clinical and dose-response analysis.
        Radiother Oncol. 1990; 18: 247-255
        • Knowles J.
        Experimental irradiation of the rat ureter: the effects of field size and the presence of contrast medium on incidence and latency of hydronephrosis.
        Radiother Oncol. 1987; 10: 59-66
        • Fokdal L.
        • et al.
        Risk factors for ureteral stricture after radiochemotherapy including image guided adaptive brachytherapy in cervical cancer: results from the EMBRACE studies.
        Int J Radiat Oncol Biol Phys. 2019; 103: 887-894
        • Demanes D.J.
        • et al.
        Ureteral stent insertion for gynecologic interstitial high-dose-rate brachytherapy.
        Brachytherapy,. 2015; 14: 245-251